| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |